FACTANKER · measured, cited, anchored official records connected

SEC EDGAR CompanyFacts fact · reporting period

VISTAGEN THERAPEUTICS, INC.: cashflow_financing

One fact, its scope and the complete path back to the official record.

Period: 2022-04-01 – 2022-12-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/d0066773-8a80-4331-91fc-c8d8f9243b78

Reported value

$-643.600k{"amount": -643600, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Entity
VISTAGEN THERAPEUTICS, INC.
Metric
cashflow_financing
Period
2022-04-01 – 2022-12-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001851734-23-000035 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T13:46:57.993870+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0001411685/cashflow-financing/2022-12-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.